JPY 4423.0
(0.52%)
Year | Revenue | Revenue Growth |
---|---|---|
2023 | 141.7 Billion JPY | 10.42% |
2022 | 128.33 Billion JPY | 6.77% |
2021 | 120.19 Billion JPY | 4.96% |
2020 | 114.51 Billion JPY | -18.78% |
2019 | 140.99 Billion JPY | -1.68% |
2018 | 143.4 Billion JPY | -3.02% |
2017 | 147.87 Billion JPY | 1.33% |
2016 | 145.92 Billion JPY | -9.84% |
2015 | 161.85 Billion JPY | 3.26% |
2014 | 156.74 Billion JPY | 4.05% |
2013 | 150.63 Billion JPY | 5.51% |
2012 | 142.77 Billion JPY | 3.61% |
2011 | 137.79 Billion JPY | 0.44% |
2010 | 137.18 Billion JPY | 5.66% |
2009 | 129.83 Billion JPY | 4.15% |
2008 | 124.65 Billion JPY | 4.7% |
2007 | 119.06 Billion JPY | 8.44% |
2006 | 109.79 Billion JPY | 6.94% |
2005 | 102.66 Billion JPY | 22.89% |
2004 | 83.54 Billion JPY | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 Q2 | 39.64 Billion JPY | 10.71% |
2024 Q1 | 35.81 Billion JPY | -7.89% |
2023 Q1 | 32.09 Billion JPY | -11.94% |
2023 Q2 | 34.88 Billion JPY | 8.68% |
2023 Q4 | 38.87 Billion JPY | 8.45% |
2023 FY | 141.7 Billion JPY | 10.42% |
2023 Q3 | 35.85 Billion JPY | 2.78% |
2022 Q1 | 26.39 Billion JPY | -21.29% |
2022 FY | 128.33 Billion JPY | 6.77% |
2022 Q2 | 33.22 Billion JPY | 25.89% |
2022 Q4 | 36.44 Billion JPY | 12.98% |
2022 Q3 | 32.26 Billion JPY | -2.9% |
2021 Q4 | 33.53 Billion JPY | 19.27% |
2021 Q1 | 27.76 Billion JPY | -17.59% |
2021 Q2 | 30.79 Billion JPY | 10.91% |
2021 FY | 120.19 Billion JPY | 4.96% |
2021 Q3 | 28.11 Billion JPY | -8.7% |
2020 Q3 | 27.89 Billion JPY | -0.53% |
2020 FY | 114.51 Billion JPY | -18.78% |
2020 Q1 | 24.88 Billion JPY | -40.64% |
2020 Q2 | 28.04 Billion JPY | 12.71% |
2020 Q4 | 33.68 Billion JPY | 20.76% |
2019 Q3 | 35.67 Billion JPY | 4.42% |
2019 FY | 140.99 Billion JPY | -1.68% |
2019 Q1 | 29.23 Billion JPY | -28.41% |
2019 Q2 | 34.16 Billion JPY | 16.88% |
2019 Q4 | 41.91 Billion JPY | 17.48% |
2018 Q3 | 33.19 Billion JPY | -7.51% |
2018 FY | 143.4 Billion JPY | -3.02% |
2018 Q1 | 33.49 Billion JPY | -12.57% |
2018 Q4 | 40.83 Billion JPY | 23.03% |
2018 Q2 | 35.88 Billion JPY | 7.12% |
2017 Q2 | 37.38 Billion JPY | 3.61% |
2017 Q1 | 36.08 Billion JPY | -0.32% |
2017 FY | 147.87 Billion JPY | 1.33% |
2017 Q4 | 38.31 Billion JPY | 6.17% |
2017 Q3 | 36.09 Billion JPY | -3.46% |
2016 Q1 | 38.15 Billion JPY | -3.58% |
2016 Q4 | 36.19 Billion JPY | 2.59% |
2016 FY | 145.92 Billion JPY | -9.84% |
2016 Q3 | 35.28 Billion JPY | -2.79% |
2016 Q2 | 36.29 Billion JPY | -4.87% |
2015 Q2 | 42.74 Billion JPY | 7.73% |
2015 Q4 | 39.56 Billion JPY | -0.72% |
2015 Q3 | 39.85 Billion JPY | -6.77% |
2015 FY | 161.85 Billion JPY | 3.26% |
2015 Q1 | 39.68 Billion JPY | -5.08% |
2014 FY | 156.74 Billion JPY | 4.05% |
2014 Q4 | 41.8 Billion JPY | 10.33% |
2014 Q3 | 37.88 Billion JPY | -3.58% |
2014 Q2 | 39.29 Billion JPY | 4.08% |
2014 Q1 | 37.75 Billion JPY | 6.34% |
2013 Q3 | 37.74 Billion JPY | -6.37% |
2013 Q4 | 35.5 Billion JPY | -5.94% |
2013 FY | 150.63 Billion JPY | 5.51% |
2013 Q1 | 37.06 Billion JPY | 4.66% |
2013 Q2 | 40.31 Billion JPY | 8.77% |
2012 Q3 | 35.42 Billion JPY | -4.93% |
2012 Q2 | 37.26 Billion JPY | 7.48% |
2012 FY | 142.77 Billion JPY | 3.61% |
2012 Q4 | 35.41 Billion JPY | -0.03% |
2012 Q1 | 34.67 Billion JPY | 1.91% |
2011 Q2 | 36.12 Billion JPY | 9.33% |
2011 Q3 | 34.61 Billion JPY | -4.17% |
2011 Q4 | 34.02 Billion JPY | -1.71% |
2011 FY | 137.79 Billion JPY | 0.44% |
2011 Q1 | 33.03 Billion JPY | -4.51% |
2010 Q2 | 38.2 Billion JPY | 16.25% |
2010 Q1 | 32.86 Billion JPY | 4.49% |
2010 Q4 | 34.6 Billion JPY | 9.83% |
2010 FY | 137.18 Billion JPY | 5.66% |
2010 Q3 | 31.5 Billion JPY | -17.55% |
2009 Q2 | 34.47 Billion JPY | 13.66% |
2009 Q1 | 30.32 Billion JPY | 0.0% |
2009 FY | 129.83 Billion JPY | 4.15% |
2009 Q4 | 31.45 Billion JPY | -6.31% |
2009 Q3 | 33.57 Billion JPY | -2.6% |
2008 FY | 124.65 Billion JPY | 4.7% |
2007 FY | 119.06 Billion JPY | 8.44% |
2006 FY | 109.79 Billion JPY | 6.94% |
2005 FY | 102.66 Billion JPY | 22.89% |
2004 FY | 83.54 Billion JPY | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
Pharma Foods International Co., Ltd. | 62.14 Billion JPY | -128.017% |
Takeda Pharmaceutical Company Limited | 4263.76 Billion JPY | 96.677% |
Sumitomo Pharma Co., Ltd. | 314.55 Billion JPY | 54.951% |
Shionogi & Co., Ltd. | 435.08 Billion JPY | 67.43% |
Wakamoto Pharmaceutical Co.,Ltd. | 7.73 Billion JPY | -1731.199% |
Nippon Shinyaku Co., Ltd. | 148.25 Billion JPY | 4.417% |
Kaken Pharmaceutical Co., Ltd. | 72.04 Billion JPY | -96.694% |
Eisai Co., Ltd. | 741.75 Billion JPY | 80.896% |
Morishita Jintan Co., Ltd. | 12.4 Billion JPY | -1042.238% |
Mochida Pharmaceutical Co., Ltd. | 102.88 Billion JPY | -37.732% |
Fuso Pharmaceutical Industries,Ltd. | 55.4 Billion JPY | -155.759% |
Nippon Chemiphar Co., Ltd. | 30.74 Billion JPY | -360.862% |
Tsumura & Co. | 150.84 Billion JPY | 6.059% |
Kissei Pharmaceutical Co., Ltd. | 75.57 Billion JPY | -87.494% |
Torii Pharmaceutical Co., Ltd. | 54.63 Billion JPY | -159.354% |
Towa Pharmaceutical Co., Ltd. | 227.93 Billion JPY | 37.83% |
Fuji Pharma Co., Ltd. | 40.88 Billion JPY | -246.563% |
Zeria Pharmaceutical Co., Ltd. | 75.72 Billion JPY | -87.132% |
KYORIN Holdings, Inc. | 119.53 Billion JPY | -18.551% |
Taiko Pharmaceutical Co.,Ltd. | 5.04 Billion JPY | -2711.627% |
Daito Pharmaceutical Co.,Ltd. | 46.89 Billion JPY | -202.177% |
SymBio Pharmaceuticals Limited | 5.58 Billion JPY | -2435.123% |
MedRx Co., Ltd | 26 Million JPY | -544923.077% |
Mizuho Medy Co.,Ltd. | 10.98 Billion JPY | -1189.44% |
Solasia Pharma K.K. | 617 Million JPY | -22866.937% |
Modalis Therapeutics Corporation | - JPY | -Infinity% |
ASKA Pharmaceutical Holdings Co.,Ltd. | 62.84 Billion JPY | -125.492% |
Sawai Group Holdings Co., Ltd. | 176.86 Billion JPY | 19.878% |
Cyfuse Biomedical K.K. | 61.11 Million JPY | -231779.173% |
Toho Holdings Co., Ltd. | 1476.71 Billion JPY | 90.404% |
Koa Shoji Holdings Co.,Ltd. | 22.13 Billion JPY | -540.214% |